摘要
目的:了解我院调节血脂药应用情况及发展趋势。方法:对我院2007～2009年的调节血脂药的销售金额、出库数量等进行统计、分析。结果:调节血脂药的销售额以每年近20%的增长速度递增,其中占主导地位的是HMG-CoA还原酶抑制剂、血脂康和阿昔莫司胶囊。结论:疗效好、价格低的调节血脂药具有良好的发展趋势。
OBJECTIVE： To investigate the the status quo and the tendency of the utilization of lipid regulating agents in our hospital. METHODS： The consumption sum and consumption quantity of the lipid regulating agents in our hospital from 2007 to 2009 were analyzed statistically. RESULTS： The consumption sum of lipid regulating agents increased at a mean annual incremental rate about 20% ,and HMG-CoA reductases inhibitors,Xuezhikang and Acipimox Capsules took the lead. CONCLUSION： The lipid regulating agents with good therapeutic effects and low price has a promising future.
出处
《中国医院用药评价与分析》
2010年第5期427-429,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
